2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26997 |
CGP-28014
|
||
CGP-28014 is an inhibitor of catechol-O-methyltransferase. CGP-28014 increases the renal excretion of both dopamine and dihydroxyphenylacetic acid (DOPAC) but does not affect renal sodium handling indicating a different mechanism of action. CGP-28014 sign | |||
T37533 |
DOPAL
|
||
DOPAL is an aldehyde product of the oxidative deamination of dopamine by monoamine oxidase.[1] It can be further oxidized to 3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase (ALDH) and, to a lesser extent reduced to 3,4-dihydroxyphenyl ethanol (DOPET). DOPAL is toxic to neurons.[2],[3] It can also oligomerize and precipitate α-synuclein, an event associated with Parkinson's disease.[2] Mice lacking cytosolic and mitochondrial forms of ALDH display increased levels of DOPAL as wel... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4907 |
3,4-Dihydroxybenzeneacetic acid
DOPAC,3,4-Dihydroxyphenylacetic acid,3,4-二羟基苯乙酸 |
Endogenous Metabolite | Metabolism |
3,4-Dihydroxybenzeneacetic acid (3,4-Dihydroxyphenylacetic acid) 是一种多巴胺的主要神经元代谢产物。 |